360 related articles for article (PubMed ID: 21891776)
1. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
[TBL] [Abstract][Full Text] [Related]
2. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
3. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
6. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
10. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
11. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
13. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
14. Vascular diseases and their risk factors in IgA nephropathy.
Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors affecting the long-term outcome of IgA nephropathy].
Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in immunoglobulin-A nephropathy.
Muthukumar T; Fernando ME; Jayakumar M
J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
20. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome.
Fofi C; Pecci G; Galliani M; Comunian MC; Muda AO; Pierucci A; Cinotti GA
J Nephrol; 2001; 14(4):280-5. PubMed ID: 11506251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
